PAIN THERAPEUTICS INC's ticker is PTIE and the CUSIP is 69562K100. A total of 46 filers reported holding PAIN THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $800,000 | -38.3% | 1,402,661 | +8.1% | 0.00% | – |
| Q3 2016 | $1,297,000 | -54.3% | 1,297,059 | 0.0% | 0.00% | – |
| Q2 2016 | $2,841,000 | -1.8% | 1,297,059 | 0.0% | 0.00% | – |
| Q1 2016 | $2,892,000 | +27.4% | 1,297,059 | 0.0% | 0.00% | – |
| Q4 2015 | $2,270,000 | -4.4% | 1,297,059 | 0.0% | 0.00% | – |
| Q3 2015 | $2,374,000 | +5.4% | 1,297,059 | -0.4% | 0.00% | – |
| Q2 2015 | $2,253,000 | -25.2% | 1,302,287 | -18.3% | 0.00% | – |
| Q1 2015 | $3,011,000 | -5.7% | 1,593,286 | +1.3% | 0.00% | -100.0% |
| Q4 2014 | $3,192,000 | -47.9% | 1,572,469 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $6,124,000 | -29.3% | 1,566,165 | +4.0% | 0.00% | 0.0% |
| Q2 2014 | $8,662,000 | +9.1% | 1,506,367 | +4.3% | 0.00% | 0.0% |
| Q1 2014 | $7,943,000 | +4.0% | 1,444,262 | -8.1% | 0.00% | 0.0% |
| Q4 2013 | $7,636,000 | +106.5% | 1,571,281 | +15.6% | 0.00% | 0.0% |
| Q3 2013 | $3,698,000 | +21.1% | 1,359,664 | -1.6% | 0.00% | 0.0% |
| Q2 2013 | $3,053,000 | – | 1,381,672 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Street Partners, LLC | 1,707,764 | $9,819,643,000 | 9.95% |
| SOPHROSYNE CAPITAL LLC | 951,362 | $5,472,000 | 5.57% |
| GREAT POINT PARTNERS LLC | 1,694,256 | $9,742,000 | 4.33% |
| INTREPID CAPITAL MANAGEMENT INC /DE/ | 436,148 | $2,508,000 | 2.19% |
| AVALON CAPITAL MANAGEMENT | 110,837 | $637,000 | 0.53% |
| Visium Asset Management, LP | 4,350,000 | $25,013,000 | 0.39% |
| Cheyne Capital Management (UK) LLP | 25,000 | $144,000 | 0.17% |
| Gruss Capital Management LP | 600,000 | $3,450,000 | 0.17% |
| Capital Impact Advisors, LLC | 31,206 | $179,000 | 0.14% |
| TFS CAPITAL LLC | 292,036 | $1,679,000 | 0.13% |